Alqaisi HA, Cohn DE, Chern JY, Duska LR, et al. Randomized phase II study of bevacizumab with weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant/refractory high grade ovarian cancer (NCI trial). Clin Cancer Res 2025 Jan 21. doi: 10.1158/1078-0432.CCR-24-3128.
PMID: 39836408